Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Pathology International
|
July 9, 2002
Peripheral T-cell lymphoma with a nodular growth pattern
Ben Hatano, Takuya Fukushima, Miyuki Honda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
December 3, 2003
[Intensive multi-drug chemotherapy for acute myeloid leukemia in a renal allograft recipient]
Jiroh Yamasaki, Tomoko Hata, Kengo Fuchigami, et al.
Nature Chemical Biology
|
June 15, 2010
Marine antifungal theonellamides target 3beta-hydroxysterol to activate Rho1 signaling
Shinichi Nishimura, Yuko Arita, Miyuki Honda, et al.
Chemical & Pharmaceutical Bulletin
|
October 3, 2014
Synthesis and antiviral activities of some 2,4,6-trisubstituted 1,3,5-triazines
Nobuko Mibu, Kazumi Yokomizo, Airi Koga, et al.
International Journal of Hematology
|
February 27, 2007
Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, Japan
Emi Matsuo, Yasushi Miyazaki, Chizuko Tsutsumi, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Pathology International
|
July 9, 2002
Peripheral T-cell lymphoma with a nodular growth pattern
Ben Hatano, Takuya Fukushima, Miyuki Honda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
December 3, 2003
[Intensive multi-drug chemotherapy for acute myeloid leukemia in a renal allograft recipient]
Jiroh Yamasaki, Tomoko Hata, Kengo Fuchigami, et al.
Nature Chemical Biology
|
June 15, 2010
Marine antifungal theonellamides target 3beta-hydroxysterol to activate Rho1 signaling
Shinichi Nishimura, Yuko Arita, Miyuki Honda, et al.
Chemical & Pharmaceutical Bulletin
|
October 3, 2014
Synthesis and antiviral activities of some 2,4,6-trisubstituted 1,3,5-triazines
Nobuko Mibu, Kazumi Yokomizo, Airi Koga, et al.
International Journal of Hematology
|
February 27, 2007
Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, Japan
Emi Matsuo, Yasushi Miyazaki, Chizuko Tsutsumi, et al.
Page
of 1